NCT06008717View on ClinicalTrials.gov

Double-Blind Clinical Trial of Subthalamic Nucleus Deep Brain Stimulation in Early-Stage Parkinson's Disease

NANot yet recruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

December 1, 2025

Primary Completion Date

April 30, 2029

Study Completion Date

August 30, 2029

Conditions
Parkinson Disease
Interventions
DEVICE

active subthalamic nucleus deep brain stimulation plus optimal drug therapy

active subthalamic nucleus deep brain stimulation (DBS) plus optimal drug therapy

DEVICE

inactive subthalamic nucleus deep brain stimulation plus optimal drug therapy

optimal drug therapy alone with DBS device turned off

All Listed Sponsors
lead

Mallory Hacker

OTHER

NCT06008717 - Double-Blind Clinical Trial of Subthalamic Nucleus Deep Brain Stimulation in Early-Stage Parkinson's Disease | Biotech Hunter | Biotech Hunter